A078160 Share Price Performance
₩16,250.00
7770.00 (91.63%)
Price ₩16,250.00
Share Price₩16,250.00
What MEDIPOST Co., Ltd.'s (KOSDAQ:078160) 25% Share Price Gain Is Not Telling You
Nov 02
MEDIPOST Co., Ltd. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
A078160 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Snowflake Analysis
MEDIPOST Co., Ltd. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- -2.54k
- 62.08%
- -137.30%
- 3.6%
About A078160
- Founded
- 2000
- Employees
- 322
- CEO
- WebsiteView website
MEDIPOST Co., Ltd. engages in the cord blood bank business in South Korea and internationally. The company operates through three divisions: Cord Blood Bank, Stem Cell Therapy, and Health Functional Food. It operates cord blood bank under the CELLTREE name. The company also offers CARTISTEM for the treatment of repetitive and/or traumatic cartilage degeneration, including degenerative osteoarthritis. In addition, it is developing stem cell products, such as PNEUMOSTEM for the preventative treatment of bronchopulmonary dysplasia. Further, the company develops SMUP-IA-01 to treat osteoarthritis; and SMUP-IV-01 for the treatment of diabetic nephropathy. Additionally, it offers nutritional and dietary supplements under the MOVITA brand name; and CDMO services. The company was founded in 2000 and is headquartered in Seongnam-si, South Korea.